WallStSmart

Expedia Group Inc. (EXPE)vsNextTrip Inc (NTRP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Expedia Group Inc. generates 312127% more annual revenue ($15.70B vs $5.03M). EXPE leads profitability with a 13.0% profit margin vs -290.0%. EXPE earns a higher WallStSmart Score of 72/100 (B).

EXPE

Strong Buy

72

out of 100

Grade: B

Growth: 7.3Profit: 7.5Value: 6.7Quality: 3.0
Piotroski: 5/9Altman Z: 0.81

NTRP

Avoid

23

out of 100

Grade: F

Growth: 8.0Profit: 2.0Value: 6.7Quality: 3.5
Piotroski: 3/9Altman Z: -8.47
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

EXPEOvervalued (-8.7%)

Margin of Safety

-8.7%

Fair Value

$215.00

Current Price

$280.83

$65.83 premium

UndervaluedFair: $215.00Overvalued
NTRPUndervalued (+79.5%)

Margin of Safety

+79.5%

Fair Value

$15.40

Current Price

$1.42

$13.98 discount

UndervaluedFair: $15.40Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EXPE5 strengths · Avg: 8.8/10
Return on EquityProfitability
168.4%10/10

Every $100 of equity generates 168 in profit

EPS GrowthGrowth
188.7%10/10

Earnings expanding 188.7% YoY

PEG RatioValuation
0.788/10

Growing faster than its price suggests

P/E RatioValuation
17.3x8/10

Attractively priced relative to earnings

Free Cash FlowQuality
$1.28B8/10

Generating 1.3B in free cash flow

NTRP1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
946.0%10/10

Revenue surging 946.0% year-over-year

Areas to Watch

EXPE3 concerns · Avg: 1.7/10
Price/BookValuation
27.9x2/10

Trading at 27.9x book value

Altman Z-ScoreHealth
0.812/10

Distress zone — elevated risk

Debt/EquityHealth
4.701/10

Elevated debt levels

NTRP4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$21.27M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-681.0%2/10

ROE of -681.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : EXPE

The strongest argument for EXPE centers on Return on Equity, EPS Growth, PEG Ratio. Revenue growth of 14.0% demonstrates continued momentum. PEG of 0.78 suggests the stock is reasonably priced for its growth.

Bull Case : NTRP

The strongest argument for NTRP centers on Revenue Growth. Revenue growth of 946.0% demonstrates continued momentum.

Bear Case : EXPE

The primary concerns for EXPE are Price/Book, Altman Z-Score, Debt/Equity. Debt-to-equity of 4.70 is elevated, increasing financial risk.

Bear Case : NTRP

The primary concerns for NTRP are EPS Growth, Market Cap, Piotroski F-Score.

Key Dynamics to Monitor

EXPE profiles as a value stock while NTRP is a hypergrowth play — different risk/reward profiles.

NTRP carries more volatility with a beta of 1.66 — expect wider price swings.

NTRP is growing revenue faster at 946.0% — sustainability is the question.

EXPE generates stronger free cash flow (1.3B), providing more financial flexibility.

Bottom Line

EXPE scores higher overall (72/100 vs 23/100) and 14.0% revenue growth. NTRP offers better value entry with a 79.5% margin of safety. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Expedia Group Inc.

CONSUMER CYCLICAL · TRAVEL SERVICES · USA

Expedia Group, Inc. is an American online travel shopping company for consumer and small business travel. Its websites, which are primarily travel fare aggregators and travel metasearch engines, include Expedia.com, Vrbo (previously HomeAway), Hotels.com, Hotwire.com, Orbitz, Travelocity, trivago and CarRentals.com.

NextTrip Inc

CONSUMER CYCLICAL · TRAVEL SERVICES · USA

Neurotrope, Inc., a biopharmaceutical company, is focused on developing a product platform for the treatment of Alzheimer's disease. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?